Mundipharma’s consumer health bought by iNova for $810m

Funds from Betadine purchase to be held in escrow to bankroll opioid crisis recompense iNova has bought Mundipharma International’s consumer health care business, centred around the Betadine product range for a USD$540 million (AUD$810 million). According to a release from iNova, Mundipharma’s beneficial owners and iNova “have agreed that all the net sale proceeds will